The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Liposomal paclitaxel formulations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Platt, V. M., & Szoka, F. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800024g · Cited by 456
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Yang, T., Cui, F.-D., Choi, M.-K., Cho, J.-W., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.011 · Cited by 385
Liposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Ruan, G., & Feng, S.-S. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00419-8 · Cited by 348
Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., & Cattel, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00166-2 · Cited by 338
(1999) · PubMed · Cited by 337
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
Uster, P. S., Allen, T. M., Daniel, B. E., Mendez, C. J., Newman, M. S., & Zhu, G. Z. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00452-8 · Cited by 298
Yang, Z., Nie, S., Hsiao, W. W., & Pam, W. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15057 · Cited by 279
Factors affecting microencapsulation of drugs in liposomes
Kulkarni, S. B., Betageri, G. V., & Singh, M. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509010292 · Cited by 261
Endothelial cell proliferation as a novel approach to targeting tumour therapy
Denekamp, J. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.16 · Cited by 249
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Yang, T., Choi, M.-K., Cui, F.-D., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.011 · Cited by 245
Cheon Lee, S., Kim, C., Chan Kwon, I., Chung, H., & Young Jeong, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00162-7 · Cited by 241
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
Immordino, M. L., Brusa, P., Arpicco, S., Stella, B., Dosio, F., & Cattel, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00271-2 · Cited by 238
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Pharmacology and Toxicology of Cremophor EL Diluent
Dorr, R. T. (1994) · Annals of Pharmacotherapy · doi:10.1177/10600280940280s503 · Cited by 227
Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes
Sharma, A., & Straubinger, R. M. (1994) · Pharmaceutical Research · doi:10.1023/a:1018994111594 · Cited by 215
Peer, D., & Margalit, R. (2004) · Neoplasia · doi:10.1593/neo.03460 · Cited by 214
A folate receptor-targeted liposomal formulation for paclitaxel
Wu, J., Liu, Q., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.027 · Cited by 212
Schmitt‐Sody, M., Strieth, S., Krasnici, S., Sauer, B., Schulze, B. G., Teifel, M., Michaelis, U., Naujoks, K., & Dellian, M. (2003) · PubMed · Cited by 192
Pharmaceutical and Physical Properties of Paclitaxel (Taxol †) Complexes with Cyclodextrins ‡
Sharma, U. S., Balasubramanian, S. V., & Straubinger, R. M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841015 · Cited by 168
Expression of CD44 in human lung tumors
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92213-6 · Cited by 161
Koshkina, N. V., Waldrep, J. C., Roberts, L., Golunski, E., Melton, S., & Knight, V. (2001) · PubMed · Cited by 154
Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability
Tao, Y., Cui, F., Choi, M., et al. (2007) · Drug Delivery · doi:10.1080/10717540601098799 · Cited by 145
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy
Yoshizawa, Y., Kono, Y., Ogawara, K., Kimura, T., & Higaki, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.008 · Cited by 144
A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration
Lundberg, B., Risovic, V., Ramaswamy, M., & Wasan, K. M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00323-1 · Cited by 144
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
Rivkin, I., Cohen, K., Koffler, J. Y., Melikhov, D., Peer, D., & Margalit, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.067 · Cited by 144
Kunstfeld, R., Wickenhauser, G., Michaelis, U., Teifel, M., Umek, W. H., Naujoks, K., Wolff, K. S., & Petzelbauer, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12057.x · Cited by 139
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model.
Sharma, A., Mayhew, E. G., & Straubinger, R. M. (1993) · PubMed · Cited by 137
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts
Sharma, A., Mayhew, E. G., Bolcsak, L. E., Cavanaugh, C., Harmon, P. A., Janoff, A. S., & Bernacki, R. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970328)71:1<103::aid-ijc17>3.0.co;2-j · Cited by 136
Tissue distribution, metabolism and excretion of paclitaxel in mice
Sparreboom, A., van Tellingen, O., Nooijen, W. J., & Beijnen, J. H. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199601000-00009 · Cited by 128
Zhang, J., Zhang, Z.-H., Yang, H., Tan, Q., Qin, S.-R., & Qiu, X.-L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2496-8 · Cited by 123
Risks and Benefits of Taxanes in Breast and Ovarian Cancer
Michaud, L. B., Valero, V., & Hortobágyi, G. N. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00005 · Cited by 121
Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells
Yang, T., Choi, M.-K., Fu-de, C., Lee, S. J., Chung, S., Shim, C., & Kim, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9425-y · Cited by 119
Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model Membranes
Balasubramanian, S. V., & Straubinger, R. M. (1994) · Biochemistry · doi:10.1021/bi00196a011 · Cited by 115
Pharmacokinetics of paclitaxel-containing liposomes in rats
Fetterly, G. J., & Straubinger, R. M. (2003) · AAPS PharmSci · doi:10.1208/ps050432 · Cited by 108
Strieth, S., Eichhorn, M., Sauer, B., Schulze, B. G., Teifel, M., Michaelis, U., & Dellian, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20083 · Cited by 104
Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.
Cabanes, A., Briggs, K., Gokhale, P. C., Treat, J., & Rahman, A. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.5.1035 · Cited by 103
Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101
Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
Kumar, G. N., Walle, U. K., Bhalla, K. N., & Walle, T. (1993) · PubMed · Cited by 98
Paclitaxel Partitioning into Lipid Bilayers
Wenk, M. R., Fahr, A., Reszka, R. C., et al. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950120i · Cited by 96
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
Zhang, Q., Huang, X., & Gao, L. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.10.001 · Cited by 93
Zhao, H., Wang, J., Sun, Q., Luo, C.-L., & Zhang, Q. (2008) · Journal of drug targeting · doi:10.1080/10611860802368966 · Cited by 92
Kan, P., Tsao, C.-W., Wang, A.-J., Su, W.-C., & Liang, H.-F. (2010) · Journal of Drug Delivery · doi:10.1155/2011/629234 · Cited by 90
Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia
Sharma, A., Sharma, U. S., & Straubinger, R. M. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04380-7 · Cited by 90
Long-circulating, polyethylene glycol-grafted immunoliposomes
Zalipsky, S., Hansen, C. B., de Menezes, D. E. L., & Allen, T. M. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00149-2 · Cited by 74
Novel Taxol formulations: Taxol-containing liposomes.
Straubinger, R. M., Sharma, A., Murray, M., & Mayhew, E. G. (1993) · PubMed · Cited by 72
The tumour microcirculation as a target in cancer therapy: a clearer perspective
Denekamp (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00558.x · Cited by 72
Zhao, P., Wang, H., Yu, M., Cao, S., Zhang, F., Chang, J. K., & Niu, R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0196-5 · Cited by 71
Effects of Cremophor EL on distribution of Taxol to serum lipoproteins
Sykes, E., Woodburn, K. W., Decker, D., & Kessel, D. H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.317 · Cited by 69
In vitroandin vivoantitumoral activity of free, and encapsulated taxol
Bartoli, M. H., Boitard, M., Fessi, H., Bériel, H., Devissaguet, J. P., Picot, F., & Puisieux, F. (1990) · Journal of Microencapsulation · doi:10.3109/02652049009021832 · Cited by 68
Liu, C., Strobl, J. S., Bane, S., Schilling, J. K., McCracken, M. A., Chatterjee, S. K., Rahim-Bata, R., & Kingston, D. G. I. (2003) · Journal of Natural Products · doi:10.1021/np030296x · Cited by 58
Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes
Meng, S., Su, B., Li, W., Ding, Y., Tang, L., Zhou, W., Song, Y., Li, H., & Zhou, C. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/41/415103 · Cited by 58
Improved Paclitaxel Formulation Hints at New Chemotherapy Approach
Garber, K. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/96.2.90 · Cited by 55
Strieth, S., Nußbaum, C., Eichhorn, M., Fuhrmann, M., Teifel, M., Michaelis, U., Berghaus, A., & Dellian, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23088 · Cited by 53
Integrin-targeted paclitaxel nanoliposomes for tumor therapy
Meng, S., Su, B., Li, W., Ding, Y., Tang, L., Zhou, W., Song, Y., & Caicun, Z. (2010) · Medical Oncology · doi:10.1007/s12032-010-9621-1 · Cited by 53
Antitumor Efficacy of Taxane Liposomes on a Human Ovarian Tumor Xenograft in Nude Mice†
Sharma, A., Straubinger, R. M., Ojima, I., & Bernacki, R. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841204 · Cited by 46
Preparation and Characterization of Taxane-Containing Liposomes
Straubinger, R. M., & Balasubramanian, S. V. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91005-7 · Cited by 45
Koudelka, Š., Turánek-Knötigová, P., Mašek, J., Korvasová, Z., Škrabalová, M., Plocková, J., Bartheldyová, E., & Tuřánek, J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21992 · Cited by 44
Self-citationTerada, T., Mizobata, M., Kawakami, S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.018 · Cited by 43
Sharma, D., Chelvi, T. P., Kaur, J., & Ralhan, R. (1998) · Melanoma Research · doi:10.1097/00008390-199806000-00006 · Cited by 41
Kim, S. C., Yoon, H. J., Lee, J. W., Yu, J.-W., Park, E., & Chi, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.011 · Cited by 37
Real-time pharmacokinetics guiding clinical decisions
Soepenberg, O., Sparreboom, A., de Jonge, M. J. A., Planting, A. S. T., de Heus, G., Loos, W. J., Hartman, C. M., Bowden, C. J., & Verweij, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.027 · Cited by 35
Kim, M., Jang, D.-H., Lee, Y., et al. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3267 · Cited by 34
Liposomes as carriers of different new lipophilic antitumour drugs: A preliminary report
Sampedro, F., Partika, J., Santaló, P., Molins‐Pujol, A. M., Bonal, J., & Perez-Soler, R. (1994) · Journal of Microencapsulation · doi:10.3109/02652049409040460 · Cited by 29
Koudelka, Š., Mašek, J., Neužil, J., & Tuřánek, J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22002 · Cited by 27
Self-citationLiposomal delivery system for taxol
Shieh, M.-F., Chu, I., Lee, C., Kan, P. L., Hau, D., & Shieh, J.-J. (1997) · Journal of Fermentation and Bioengineering · doi:10.1016/s0922-338x(97)87332-1 · Cited by 24
Extensive and saturable accumulation of paclitaxel by the human platelet
Wild, M. D., Walle, U. K., & Walle, T. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685730 · Cited by 21
Wang, X., Zheng, H., Zhu, Z., Wei, Y., & Chen, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22169 · Cited by 13
Lu (1999) · doi:10.1002/(sici)1097-4636(199908)46:2
(1989) · PubMed
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 877
Cragg, G. M., & Pezzuto, J. M. (2016) · Medical Principles and Practice · doi:10.1159/000443404 · Cited by 798
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
Metadata
- Authors
- Koudelka, Š., & Turánek, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 163
- Issue
- 3
- Pages
- 322-334
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2020678484
- Cited by
- 366
- References
- 83
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.